Cipher Pharmaceuticals Inc (CPH.TO) has seen a slight decline in its stock price this week, despite strong financial performance in previous quarters.
This week, Cipher Pharmaceuticals Inc (TSX: CPH) experienced a minor setback, closing at C$16.75, down 1.34% for the day and 1.97% over the week. However, the company has shown solid growth in its financials over the past year, making it a notable player in the health care sector.
Advertisement
Cipher Pharmaceuticals Inc
CPH.TO
CPH.TO
Cipher Pharmaceuticals Inc
WealthAwesomeAdvertisement
Market cap
$356.72M
P/E
8.5x
52W high
$20.56
52W low
$12.48
1W change
-21.18%
Beta
0.46
Analyst Price Targets
Based on analyst covering CPH
Wall Street analysts forecast CPH stock price to rise 47.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$20.64
+47.5% Upside
Current Price
C$13.99
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CPH's historical volatility
30-Day Vol
73.8%
Annualized
90-Day Vol
51.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$11.70
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$13.18 | C$10.22 – C$17.01 |
| 60 trading days | C$12.42 | C$8.66 – C$17.81 |
| 90 trading days | C$11.70 | C$7.53 – C$18.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should consider the recent price movements alongside favorable earnings reports from earlier this year. The company's strong profit margins and low beta indicate a relatively stable investment, though short-term volatility is still a factor.
Cipher Pharmaceuticals Inc's stock is down 1.34% today, closing at C$16.75.
The stock has seen a year-to-date increase of 13.42%, reflecting the company's strong financial performance despite recent price fluctuations.
Bull case
Cipher Pharmaceuticals has demonstrated impressive growth, with a 135% increase in net income reported for Q1 2026 compared to the same period in 2025. This trend of increasing profitability could boost investor confidence moving forward.
Bear case
Despite the strong fundamentals, recent price declines may suggest investor caution or profit-taking. The stock's performance below the 50-day moving average indicates potential weakness in the short term.
Recent Price Action
Cipher Pharmaceuticals Inc's stock has closed at C$16.75, reflecting a 1.34% decrease for the day and a 1.97% decline over the past week. The stock has shown a year-to-date increase of 13.42%, indicating a generally positive trend despite recent fluctuations.
Advertisement
Company News and Financial Performance
There have been no major company news announcements this week. However, Cipher Pharmaceuticals recently reported strong financial results, including a net income of $6.2 million for Q1 2026, a 135% increase compared to the same quarter in 2025. This follows a trend of record revenue and earnings for 2025, with total revenue reaching $50.5 million, a 51% increase from the previous year.
Technical Picture
The technical indicators for CPH.TO show a last close of C$16.75, with a 50-day moving average of C$16.96, indicating the stock is trading below this level. The 200-day moving average stands at C$15.82, showing a positive 5.9% difference from the current price. The stock has a beta of 0.48, suggesting lower volatility compared to the broader market. Recent trading volume was 6,999 shares, which is 1.35 times the 20-day average volume of 13,270 shares.
Insider Activity
No insider activity has been reported this week, which may suggest stability in the company's management and operations.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
